Joy Behar and the panel at The View are at it again, and this time their latest meltdown is over something that would normally be hard to argue with: cheaper prescription drugs.
But when Donald Trump is involved, even savings apparently become suspect.
The uproar began after Trump-linked efforts tied to the “Trump Rx” initiative started getting attention for lowering prescription costs. In a twist that would make cable news producers weep with joy, even longtime Trump critic and businessman Mark Cuban has reportedly engaged with the administration on the effort to reduce drug prices—despite once spending years sharpening rhetorical knives against the former president on the campaign trail and late-night TV circuits.
But The View crew didn’t exactly take the news as a public service announcement. Joy Behar, never one to understate her feelings about Trump-era initiatives, went on the offensive and urged skepticism—if not outright avoidance—of the program, prompting yet another round of debate over whether the show is offering commentary or just daily therapy sessions for Trump-related frustration.
That’s where Dr. Mehmet Oz, currently serving in the administration’s health policy orbit, decided to step into the conversation—with a punchline.
https://t.co/8XMXPxEXtl pic.twitter.com/1brcfTOarK
— DrOzCMS (@DrOzCMS) May 20, 2026
Responding to the panel’s latest objections, Oz jokingly suggested that a “prescription” for the hosts’ condition might be in development, a tongue-in-cheek reference that immediately ricocheted across social media. The implication was clear enough for supporters: if Trump Derangement Syndrome were treatable, he’d be first in line to write the script.
The reaction online was immediate and predictable. Trump supporters amplified the clip, mocking what they saw as performative outrage from daytime television personalities who routinely rail against the administration while ignoring policy outcomes they don’t like.
One social media user praised the exchange, writing, “This Cabinet is the best Cabinet,” while others piled on with memes claiming to have invented “cures” for political hysteria—most of them involving humor, not medicine.
Critics of Behar, meanwhile, argued that her warnings about Trump Rx crossed into fear-mongering territory, especially given that the program deals with the same types of medications available through traditional pharmacies—just at lower cost.
Others pushed back on the broader tone of the segment, saying The View continues to blur the line between commentary and alarmism whenever Trump’s name is attached to a policy proposal.
Still, the underlying irony wasn’t lost on supporters: a show that regularly promotes trust in institutions suddenly urging viewers to distrust a cost-saving healthcare initiative simply because of its political branding.
And while the cable news circus churns on, the policy itself continues to do what it was designed to do—generate savings for patients navigating America’s notoriously expensive prescription market.
As for Dr. Oz’s viral quip, it landed exactly the way modern political humor often does: half joke, half Rorschach test. To supporters, it was a witty takedown of media hysteria. To critics, it was proof the administration can’t resist punching back.
Either way, the segment achieved what The View almost always guarantees: attention, outrage, and another day in the endless cycle of political theater disguised as daytime television.
